Abstract: Novel azo-bis-ebselen compounds 7 were prepared by reduction of 7-nitro-2-aryl-1,2-benzisoselenazol-3(2H)-ones 3 and 6 with sodium benzenetellurolate, NaTeC6H5, and by reaction of 2-bromo-3-nitrobenzamides with Na2Se2. The X-ray structure of 7b showed that the molecule, due to strong intramolecular secondary Se···N interactions, is completely planar. Azo-compounds 7 upon further reaction with NaTeC6H5 were reductively cleaved to provide two equivalents of the corresponding aromatic amine. The weak Se─N bond was not stable enough to survive the reaction conditions and diselenides 8 were isolated after work-up. Whereas azo-bis-ebselens 7 were poor mimics of the glutathione peroxidase (GPx)-enzymes, nitroebselens 3, 6 and 11b and diselenides 8 were 3-6 fold more active than ebselen. Based on 77 Se NMR spectroscopy, a catalytic cycle for diselenide 8b, involving aminoebselen 14, was proposed. As assessed by chemiluminescence measurements, the good GPx-mimics could reduce production of reactive oxygen species (ROS) in stimulated human mononuclear cells more efficiently than Trolox. No toxic effects of the compounds were seen in MC3T3-cells at 25 M.
Introduction
Selenocysteine (Sec, 1) is recognized as the 21 st proteinogenic amino acid. It is an essential part of the active site of selenoproteins in humans and animals. So far, 23 selenoprotein families have been annoted. 1 The human selenoproteome consists of 25 selenoproteins. 2 Whereas some of these have a known structure and function (GPx, iodothyronine deiodinases, thioredoxin reductases) 3, 4 others are as yet insufficiently characterized. The substitution of selenium for sulfur in cysteine (Cys) has many implications. 5 At physiological pH, the more acidic selenol (pKa = 5.43) 6 is essentially deprotonated.
Sec is therefore a more reactive nucleophile than Cys. Also, redox-cycling (oxidation/reduction) occurs more readily in Sec than in Cys. In addition to catalase, the GPx-enzymes are the most important hydroperoxide-decomposing enzymes in humans. 7 Gluthathione (GSH) is used as the stoichiometric reducing agent (eq 1). In the proposed catalytic cycle for the action of the GPxenzymes selenium is present in the form of selenol, selenenic acid and selenosulfide. 8 The reports on the existence of GPx triggered a search for small-molecule compounds that could mimic the action of the large enzyme. The benzisoselenazolone ebselen (2) was the first compound of this kind. 9 Since the mid 1980s, the suitability of ebselen as a pharmaceutical agent has been extensively probed. Due to its GPx-activity, it has been found to reduce oxidative stress. 10 It is/has been used in clinical trials for the prevention or treatment of cardiovascular diseases, arthritis, stroke and cancer. 11 Considered as a safe drug-like compound with a history of use in human clinical trials, ebselen has also been included in the National Institutes of Health Clinical Collection. 12 Ebselen has been subjected to numerous structural modifications in order to improve its GPx-activity. 13 An early study by Parnham and co-workers showed that the nitro-derivative 3 of ebselen was 9-fold better than the parent as a catalyst for the glutathione-induced reduction of t-BuOOH. 14 However, this finding has not been much explored and the reason for the rate enhancement has been attributed both to electronic 15 and steric 16 effects.
benzisoselenazolones 3/6b-c involved aromatic nucleophilic substitution with n BuSeNa, generated in situ from Bu2Se2 and NaBH4 in ethanol, followed by bromine induced cyclization.
Reduction of the nitro group in the presence of the weak Se-N bond turned out to be difficult.
Sodium benzenetellurolate, NaTePh, 19 generated in ethanol by sodium borohydride reduction of diphenyl ditelluride (Ph2Te2), was found to cleanly reduce compound 3 to azo-bis-ebselen derivative 7a in 51% yield. However, in the case of 6b, the corresponding azo-derivative 7b was isolated as the minor product (9%) along with diselenide 8b (16%). Obviously, in 8b, the nitro group has been reduced all the way to an amine and the Se-N bond cleaved reductively. Oxidation of the resulting selenol then provided the diselenide product. Reduction of azo-compound 7b with NaTePh produced diselenide 8b as the only product (87%).
An alternative method for the preparation of azo-derivatives of ebselen was also tried. This is based on the finding that 2-bromo-3-nitrobenzylic alcohols, when reacted with disodium diselenide (Na2Se2) produced azo-derivatives 9 of 2-oxaselenaindane. 20 Reaction of in situ-prepared Na2Se2 with compounds 4a-d at ambient temperature produced the corresponding azo-bis-ebselens 7a (29%), 7b (39%), 7c (21% when heated at reflux) and 7d (68%) (eq 3). Due to poor solubility, we were unable to characterize the methoxy derivative 7c.
Further reaction of compound 7d with NaTePh afforded diselenide 8d in 52% yield. Under the similar reaction conditions, benzamides 5a-c, carrying a butylseleno group in position 2, were cleanly reduced to the corresponding amines 10a-c in high yields. We recently reported on the cytoprotective effects of the radical-trapping and hydroperoxide-decomposing ebselenol 11a.
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Curious about the effects of an ortho-coordinating nitro group, compound 6c was O-demethylated with 3 equivalents of BBr3 in CH2Cl2 to afford the nitroebselenol 11b in 88% yield.
Structure: The structures of azo-bis-ebselen derivative 7b and diselenide 8b were determined by X- shorter than the sum of the van der Waals radii of selenium and hydrogen (3.10 Å). Information). The optimized geometry of 7b showed good agreement with the X-ray crystal structure. The structures of 7a and 7d were also found to be completely planar with strong Se···N interactions. The second perturbation energies ESe···N and ESe···O shown in Table 1 The topology of the electron density at the Se···N/O bond critical point (BCP) was evaluated according to Bader's theory of atoms in molecules (AIM) using the AIM2000 software package (for molecular graphs, see Figure Glutathione Peroxidase-like Activity: The GPx-like activity of antioxidants 2-3, 6b-c, 7a-b, 7d, 8b, 8d and 11b was assessed by the coupled reductase assay, using H2O2 as a substrate and GSH as a thiol cofactor in the presence of glutathione reductase (GR). GR serves to reduce oxidized glutathione (GSSG) formed by the action of the GPx-catalyst on H2O2/GSH, using β-nicotinamide adenine dinucleotide phosphate (NADPH) as a cofactor. GPx-activities were assessed as the initial rates (0) for the consumption of NADPH by UV-spectroscopy at 340 nm during the initial 10 seconds of reaction. The values shown in were included as bench-marks and references in the study. Nitroebselens 6b, 6c and 11b were found to be nearly three times more active than ebselen (2) , and slightly better than 3. This enhanced activity of the nitro compounds can probably be ascribed to intramolecular secondary Se···O interactions. Such or similar effects are well described in the literature. 14,17,20b,24 Azoebselens 7a, 7b
and 7d turned out to be considerably poorer GPx-mimics than 2 and 3. Interestingly, diselenide 8b
showed an activity (271.6  5.7 µMmin -1 ) almost six-fold larger than recorded for ebselen. The other diselenide 8d, carrying a bulky naphthyl group, also showed good GPx-activity (133.8  2.7 µMmin -1 ). Consumption of Hydrogen Peroxide: The performance of some of the best GPx-mimics 8b, 8d and 11b (10 mol%) together with GSH, NADPH, GR and H2O2 in phosphate buffer was also followed for much longer time (250 min). As shown in Figure 3 , a significant decrease in the absorbance of NADPH was seen during ca. 80 min. Thereafter, the consumption of NADPH corresponds more or less to the background reaction. Ebselen (2), included as a reference in Figure 3 , could not match the activity of 8b, 8d and 11b. Se NMR spectrum. When GSH (1 equivalent) was added to a solution of 8b in DMSO-d6, the peak for 16 at δ = 346 ppm appeared.
Scheme 1. Proposed mechanism for the reduction of H2O2 in the presence of GSH and diselenide 8b
It is not surprising that the peak from selenol 16 is shifted only 25 ppm upfield from that of diselenide 8b. This is due to strong intramolecular secondary Se···O interactions with the carbonyl group and additional substituent effects from the aromatic rings. A similar downfield chemical shift of 232 ppm for the corresponding selenol derived from ebselen was also accounted for in terms of strong Se···O interactions. 24b In none of the above experiments did we see a peak corresponding to selenosulfide 15. It is probably a highly reactive species. We speculate that hydrogen bonding of Se to the ortho-amino group facilitates attack by thiol. (2) and Trolox at 25 M. The total chemiluminescence (CL; extra-and intracellular) was then recorded in a luminol amplified assay. As shown in Figure 4 , CL was significantly reduced for all compounds tested. Good GPx-mimics such as nitro compounds 6b, 6c and 11b and diselenide 8b all afforded better cytprotection than Trolox. Nitroebselenol 11b was by far the most potent protective agent. 
Conclusion
In search for novel ebselen derivatives with improved antioxidative properties we have described straightforward syntheses of azo-bis-ebselens from nitroebselens and 2-bromo-3-nitrobenzamides. Reduction of the azo-group to the corresponding amine was effected by NaTePh, but this transformation was accompanied by cleavage of the Se-N bond, resulting in formation of diaryl diselenides carrying both amino-and benzamide groups in the ortho positions. As revealed by X-ray crystallography and DFT-calculations, the intramolecular Se···N-coordination in azo-bisebselens was much stronger than the corresponding Se···O-interaction in nitroebselens. This may be the reason for the poor GPx-activity of the azo-bis-ebselens. Both nitroebselens 6 and diselenides 8 outperformed ebselen when it comes to catalysis of GSH-induced reduction of hydrogen peroxide.
Considering their low toxicity and ability to inhibit ROS/RNS in stimulated human MNC-cells, we feel that compounds of this sort would be useful as models and tools in the development of novel treatments for diseases with a component of oxidative stress (cardiovascular diseases, stroke, Alzheimer's and Parkinson's diseases).
Experimental Section
2-Bromo-3-nitrobenzoic acid (98% purity) was purchased and used as such. 1 The resulting solution was then stirred for overnight. The reaction mixture was poured in water (10 mL) and extracted with dichloromethane. The separated organic layers were combined, dried over anhydrous Na2SO4 and the solvent was evaporated under reduced pressure. The crude residue was purified by column chromatography on silica gel using ethyl acetate/n-pentane (1:1) as an eluent to
give the title product (1.13 g, 87%) as a solid. Physical and spectroscopic data were in good agreement with the literature. 17 The 1 H and 13 C NMR spectra of 4a have been included in the Supporting Information. washed with water. After drying over anhydrous Na2SO4, evaporation of the solvent and column chromatography using 20% ethyl acetate/pentane as eluent, the pure title compound (0.51 g, 55%)
2-Bromo-3-nitro-N-p-tolylbenzamide (4b

2-Bromo-N-(4-methoxyphenyl)-3-nitrobenzamide (4c
was isolated. Physical and spectroscopic data were in good agreement with the literature. 17 The 1 H,
13
C and 77 Se NMR spectra of 5a have been included in the Supporting Information. 
2-Butylseleno-3-nitro-N-p-tolylbenzamide (5b). Orange liquid (semi-solid
2-Butylseleno-N-(4-methoxyphenyl)-3-nitrobenzamide (5c
2-(p-Methoxyphenyl)-7-nitro-1,2-benzisoselenazol-3(2H)-one (6c
Typical procedure B for the preparation of azo-bis-ebselen compounds: Bis-[2-phenyl-1,2-benzisoselenzol-3-(2H)-one-7-yl]diazene (7a).
To a brown suspension of in situ prepared Na2Se2
(1.24 mmol) in dry THF (20 mL) under an inert atmosphere was slowly added a solution of benzamide 4a (0.20 g, 0.62 mmol) in THF (10 mL) at room temperature. After heating at reflux for 5h and cooling to room temperature, water (20 mL) was added and stirring was continued for 10 min. Following extraction with CHCl3, the combined organic layers were dried over anhydrous Na2SO4. Removal of the solvent and purification of the residue by silica gel column chromatography, eluting first with pentane/ethyl acetate (50:50) then with CHCl3 and finally with CHCl3/MeOH (98:2), afforded compound 7a (62 mg, 35%). Similarly, compound 7b (340 mg, 36%) was prepared from 4b (1.00 g, 2.98 mmol).
Bis-[1-naphthyl-1,2-benzisoselenzol-3-(2H)-one-7-yl]diazene (7d).
The solution of 4d and Na2Se2 was stirred for 8 h at room temperature before workup. Purification by column chromatography using 5% MeOH/CHCl3 as an eluent afforded the title compound (68%) as a dark brown solid. Mp Diselenide 8b was also isolated in 16% yield when 6b was allowed to react with NaTePh.
Typical procedure for reduction of 2-butylseleno-3-nitrobenzamides: 3-Amino-2-butylseleno-
N-phenyl benzamide (10a).
To in situ-prepared NaTePh (0.96 mmol) from the reaction of Ph2Te2
(192 mg, 0.48 mmol) and NaBH4 (35 mg, 0.94 mmol) in EtOH (10 mL) was added 5a (96 mg 0.24 mmol) at room temperature under nitrogen. The mixture was then heated at reflux for overnight. were unique (Rint = 0.0599).
3-Amino-2-(butylseleno)-N-(4-methoxyphenyl)benzamide (10c
Computational details.
Computational calculations for compounds 6b-c, 7a-b, 7d, 11b were executed by using the Gaussian 09 suite of quantum chemical programs. 29 The hybrid B3LYP exchange correlation functional was implemented for density functional theory (DFT) calculations.
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The geometry optimizations were carried out at the B3LYP level of DFT by using the 6-311+G(d) basis sets. were based on the consumption of NADPH as assessed by UV-spectroscopy at 340 nm. The initial reduction rates were triplicated and calculated from the first 10 seconds of reaction by using 6.22 mM -1 cm -1 as the extinction coefficient for NADPH. GPx-data reported in Table 2 are means ± SD.
Biological Studies. Blood buffy coats were diluted in a 1:1 ratio with 1 x phosphate buffered saline (PBS) and mononuclear cells were segregated using Ficoll-Paque plus density gradient centrifugation. Briefly, the diluted blood was gently placed on top of Ficoll-Paque and then centrifuged at 400 g for 30 minutes. After removing the plasma layer, the mononuclear (MNC) layer was collected, washed with PBS, and then spun at 100 g for 15 min. This washing procedure was repeated for a total of 3 times. Total cell number was counted using a hemocytometer and trypan blue exclusion method. The blood pellet was then suspended in 3% dextran/0.9% saline for 20 min.
The supernatant was then collected and the cell pellet collected after centrifugation at 250 g for 10 min. To remove erythrocyte, the pellet was subjected to 0.2% saline solution for 20 s and then an equal volume of 1.6% saline was added. Then the cells were spun at 250 g for 10 min and the pellet was suspended in PBS.
Chemiluminescence Assay. To measure release of ROS from monocytes, a luminol amplified chemiluminescence assay was conducted. All measurements were performed in white 96 well plates at 37°C in 1 x PBS with 50 mM of luminol, 0.1M NaOH, 2 μg/mL of horse radish peroxidase, 
